• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TGF-β 与雌激素受体信号通路在乳腺癌中的相互作用。

Crosstalk of TGF-β and estrogen receptor signaling in breast cancer.

机构信息

Molecular Cancer Biology Program, Biomedicum Helsinki and Haartman Institute, University of Helsinki, Helsinki, Finland.

出版信息

J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):109-15. doi: 10.1007/s10911-011-9203-7. Epub 2011 Mar 11.

DOI:10.1007/s10911-011-9203-7
PMID:21390570
Abstract

Estrogen receptor-α (ERα) and transforming growth factor (TGF)-β signaling pathways are major regulators during mammary gland development, function and tumorigenesis. Predominantly, they have opposing roles in proliferation and apoptosis. While ERα signaling supports growth and differentiation and is antiapoptotic, mammary gland epithelia cells are very sensitive to TGF-β-induced cell cycle arrest and apoptosis. Their regulatory pathways intersect, and ERα blocks TGF-β pathway by multiple means, including direct interactions of its signaling components, Smads. However, relatively little is known of the dysfunction of their interactions in cancer. A better understanding would help to develop new strategies for breast cancer treatment.

摘要

雌激素受体-α(ERα)和转化生长因子(TGF)-β信号通路是乳腺发育、功能和肿瘤发生过程中的主要调节因子。它们主要在增殖和凋亡方面发挥相反的作用。虽然 ERα 信号支持生长和分化,并具有抗凋亡作用,但乳腺上皮细胞对 TGF-β诱导的细胞周期停滞和凋亡非常敏感。它们的调节途径相互交叉,ERα 通过多种方式阻断 TGF-β 途径,包括其信号成分 Smads 的直接相互作用。然而,它们相互作用的功能障碍在癌症中的相关信息相对较少。更好地了解这一点将有助于为乳腺癌治疗开发新策略。

相似文献

1
Crosstalk of TGF-β and estrogen receptor signaling in breast cancer.TGF-β 与雌激素受体信号通路在乳腺癌中的相互作用。
J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):109-15. doi: 10.1007/s10911-011-9203-7. Epub 2011 Mar 11.
2
Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands.雌激素受体 alpha 可独立于激动剂和拮抗剂配体减弱乳腺癌细胞中的转化生长因子-β信号。
Breast Cancer Res Treat. 2010 Apr;120(2):357-67. doi: 10.1007/s10549-009-0393-2. Epub 2009 Apr 16.
3
Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation.雌激素通过促进 Smad2/3 降解来抑制转化生长因子-β信号通路。
J Biol Chem. 2010 May 7;285(19):14747-55. doi: 10.1074/jbc.M109.093039. Epub 2010 Mar 5.
4
Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro.体外,转化生长因子-β信号通路与雌激素受体α信号通路在调节酚类环境雌激素激活的子宫肌瘤生长方面存在相互作用。
Tumour Biol. 2016 Jan;37(1):455-62. doi: 10.1007/s13277-015-3813-4. Epub 2015 Jul 30.
5
Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines.在乳腺癌细胞系中,转化生长因子-β1(TGF-β1)增强蛋白酶体依赖性的雌激素受体α降解。
J Cell Biochem. 2003 Jan 1;88(1):181-90. doi: 10.1002/jcb.10353.
6
SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.SnoN 癌蛋白增强雌激素受体-α 的转录活性。
Cell Signal. 2012 Apr;24(4):922-30. doi: 10.1016/j.cellsig.2011.12.015. Epub 2011 Dec 29.
7
Estrogen receptor-α-miR-1271-SNAI2 feedback loop regulates transforming growth factor-β-induced breast cancer progression.雌激素受体-α- miR-1271-SNAI2 反馈环调控转化生长因子-β诱导的乳腺癌进展。
J Exp Clin Cancer Res. 2019 Mar 1;38(1):109. doi: 10.1186/s13046-019-1112-4.
8
MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.miRNA-455-3p 通过抑制 TGF-β 信号通路介导 GATA3 在乳腺上皮细胞中的抑瘤作用。
J Biol Chem. 2019 Oct 25;294(43):15808-15825. doi: 10.1074/jbc.RA119.010800. Epub 2019 Sep 6.
9
Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.苯并吡喃衍生物 CDRI-85/287 通过调节雌激素受体 α 和 β 介导的信号,与 EGFR 信号平行,诱导雌激素受体阳性乳腺癌细胞的 G2-M 期阻滞,并抑制肿瘤异种移植物的生长。
Steroids. 2013 Nov;78(11):1071-86. doi: 10.1016/j.steroids.2013.07.004. Epub 2013 Jul 26.
10
AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer.AKT改变全基因组雌激素受体α的结合,并影响乳腺癌中的雌激素信号传导。
Mol Cell Biol. 2008 Dec;28(24):7487-503. doi: 10.1128/MCB.00799-08. Epub 2008 Oct 6.

引用本文的文献

1
Unveiling Epigenetic Regulatory Elements Associated with Breast Cancer Development.揭示与乳腺癌发展相关的表观遗传调控元件。
Int J Mol Sci. 2025 Jul 8;26(14):6558. doi: 10.3390/ijms26146558.
2
Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption.胱抑素M/E可改善多发性骨髓瘤诱导的高溶骨性骨吸收。
Cancers (Basel). 2025 Feb 27;17(5):833. doi: 10.3390/cancers17050833.
3
Unveiling epigenetic regulatory elements associated with breast cancer development.揭示与乳腺癌发展相关的表观遗传调控元件。

本文引用的文献

1
FOXA1 is a key determinant of estrogen receptor function and endocrine response.FOXA1 是雌激素受体功能和内分泌反应的关键决定因素。
Nat Genet. 2011 Jan;43(1):27-33. doi: 10.1038/ng.730. Epub 2010 Dec 12.
2
SnoN in mammalian development, function and diseases.SnoN 在哺乳动物发育、功能和疾病中的作用。
Curr Opin Pharmacol. 2010 Dec;10(6):670-5. doi: 10.1016/j.coph.2010.08.006. Epub 2010 Sep 6.
3
Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation.
bioRxiv. 2024 Nov 15:2024.11.12.623187. doi: 10.1101/2024.11.12.623187.
4
Transcriptional responses to direct and indirect TGFB1 stimulation in cancerous and noncancerous mammary epithelial cells.在癌变和非癌变乳腺上皮细胞中,TGFB1 的直接和间接刺激的转录反应。
Cell Commun Signal. 2024 Oct 28;22(1):522. doi: 10.1186/s12964-024-01821-5.
5
Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influx.胱抑素M/E通过增加破骨细胞雌激素内流来改善骨吸收。
Res Sq. 2024 May 6:rs.3.rs-4313179. doi: 10.21203/rs.3.rs-4313179/v1.
6
Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer-directs the road towards therapy resistance, metastatic progression and recurrence.糖皮质激素受体:乳腺癌细胞可塑性的协调者——指向治疗耐药、转移进展和复发的方向。
Cancer Metastasis Rev. 2024 Mar;43(1):481-499. doi: 10.1007/s10555-023-10163-6. Epub 2024 Jan 3.
7
Sex-biased TGFβ signalling in pulmonary arterial hypertension.肺动脉高压中的性别偏倚 TGFβ 信号传导。
Cardiovasc Res. 2023 Oct 24;119(13):2262-2277. doi: 10.1093/cvr/cvad129.
8
WFDC3 inhibits tumor metastasis by promoting the ERβ-mediated transcriptional repression of TGFBR1 in colorectal cancer.WFDC3 通过促进 ERβ 介导的 TGFBR1 的转录抑制来抑制结直肠癌的转移。
Cell Death Dis. 2023 Jul 13;14(7):425. doi: 10.1038/s41419-023-05956-0.
9
Polyploid giant cancer cells, cytokines and cytomegalovirus in breast cancer progression.多倍体巨癌细胞、细胞因子与巨细胞病毒在乳腺癌进展中的作用
Cancer Cell Int. 2023 Jun 20;23(1):119. doi: 10.1186/s12935-023-02971-1.
10
LINC01116 affects patient survival differently and is dissimilarly expressed in ER+ and ER- breast cancer samples.LINC01116 对 ER+和 ER-乳腺癌样本的患者生存影响不同,且表达情况也不同。
Cancer Rep (Hoboken). 2023 Aug;6(8):e1848. doi: 10.1002/cnr2.1848. Epub 2023 Jun 15.
全基因组分析雌激素受体 α DNA 结合和连接机制,发现 Runx1 是受体介导的转录激活中的一种新型连接因子。
Mol Cell Biol. 2010 Aug;30(16):3943-55. doi: 10.1128/MCB.00118-10. Epub 2010 Jun 14.
4
Transforming growth factor-beta regulator SnoN modulates mammary gland branching morphogenesis, postlactational involution, and mammary tumorigenesis.转化生长因子-β调节因子 SnoN 调节乳腺分支形态发生、泌乳后 involution 和乳腺肿瘤发生。
Cancer Res. 2010 May 15;70(10):4204-13. doi: 10.1158/0008-5472.CAN-10-0135. Epub 2010 May 11.
5
ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.ERβ 通过使 HIF-1α 不稳定并抑制 VEGF 介导的 snail 核定位来阻碍前列腺癌 EMT:对 Gleason 分级的影响。
Cancer Cell. 2010 Apr 13;17(4):319-32. doi: 10.1016/j.ccr.2010.02.030.
6
Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation.雌激素通过促进 Smad2/3 降解来抑制转化生长因子-β信号通路。
J Biol Chem. 2010 May 7;285(19):14747-55. doi: 10.1074/jbc.M109.093039. Epub 2010 Mar 5.
7
Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.抗雌激素可诱导乳腺癌中转化生长因子β介导的免疫抑制。
Cancer Res. 2010 Feb 15;70(4):1314-22. doi: 10.1158/0008-5472.CAN-09-3292. Epub 2010 Feb 9.
8
Dual effects of TGF-beta on ERalpha-mediated estrogenic transcriptional activity in breast cancer.TGF-β 对乳腺癌中 ERα 介导的雌激素转录活性的双重影响。
Mol Cancer. 2009 Nov 27;8:111. doi: 10.1186/1476-4598-8-111.
9
The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7.磷脂酰肌醇 3-激酶/蛋白激酶 B 通路通过使 Ski 不稳定和诱导 Smad7 来调节转化生长因子-β信号转导。
J Biol Chem. 2009 Dec 18;284(51):35441-9. doi: 10.1074/jbc.M109.029488.
10
Gain or loss of TGFbeta signaling in mammary carcinoma cells can promote metastasis.乳腺癌细胞中转化生长因子β(TGFβ)信号的获得或丧失可促进转移。
Cell Cycle. 2009 Oct 15;8(20):3319-27. doi: 10.4161/cc.8.20.9727. Epub 2009 Oct 4.